Regentis Biomaterials Ltd. (RGNT) stock
RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$1.14−0.08 (-6.56%)
Close on Nov 18, 2026Market cap $5.90MP/E –Yield –
Regentis Biomaterials net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -$13.65M, down 384.3% from the year before.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.65M | -384.3% |
| FY2024 | Dec 31, 2024 | $4.80M | – |
| FY2023 | Dec 31, 2023 | -$4.13M | – |
See a number that looks wrong?